BMP7 and diabetic cardiomyopathy: We have shown in this study that BMP7 AAV gene therapy has some efficacy in attenuating diabetes-induced changes in cardiac structure and function and provides the pre-clinical groundwork into the potential use of cardiac-targeted gene therapy for limiting the progression of diabetic cardiomyopathy, such as we have recently postulated (Prakoso et al., 2021b).